ASCO
Structured Exercise Improves Survival In Patients With Stage II/III Colon Cancer
A structured exercise program after adjuvant chemotherapy in patients with high-risk stage II or III colon cancer ...
JULY 18, 2025
Mixed Results Seen for PREEMPT CRC Screening Test
The PREEMPT CRC study met its primary end points but with a lower magnitude of benefit than investigators had ...
JUNE 6, 2025
Structured Exercise Improves Survival in Stage II/III Colon Cancer
A structured exercise program after adjuvant chemotherapy in patients with high-risk stage II or III colon cancer ...
JUNE 4, 2025
New Screening/Surveillance Approaches For BE May Uncover More Cancers
Improved means for preventing esophageal cancer, including nonendoscopic screening and molecular surveillance for ...
APRIL 21, 2025
AI-Based Patient Navigator Improves Colonoscopy Rates in Underserved Community
The use of a conversational artificial intelligence–based patient navigator doubled the colonoscopy ...
SEPTEMBER 2, 2024
Majority of Patients With Lynch Syndrome Don’t Use Aspirin for CRC Prevention
Only a minority of patients with Lynch syndrome may be taking aspirin to prevent colorectal cancer despite its ...
JULY 2, 2024
Disparities in Survival and Driver Mutations In CRC Shown in Large Database
An evaluation of a large cohort of CRC patients has revealed substantial racial disparities in overall survival and ...
APRIL 26, 2024
Center for Young-Onset Colorectal Cancer At Dana-Farber Aims to Meet Unique Challenges
People diagnosed with CRC before 50 years of age comprise a population with its own set of circumstances and needs. ...
APRIL 16, 2024
High-Risk Groups Would Benefit From Gastric Cancer Screening
Although there's not universal screening for gastric cancer in the United States, high-risk groups deserve ...
APRIL 9, 2024
Blood-Based Tests Will Be Game Changers For Cancer Screening
To meet the increased CRC screening demands, clinicians need to use all available modalities—including stool- ...
APRIL 1, 2024
Albumin-Bilirubin Grade Proposed as Prognostic Tool in Hepatocellular Carcinoma
Results of a retrospective study suggest that the albumin-bilirubin grade might be more useful in classifying ...
OCTOBER 30, 2023
Novel First-Line Therapy’s OS Benefit for Liver Cancer Persists
Long-term overall survival in hepatocellular carcinoma with tremelimumab plus durvalumab treatment is durable, ...
OCTOBER 27, 2023
